A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors

Name: A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors
Published: 2021
License: Public Domain

Elicio Therapeutics · 2021

ClinicalTrials.gov · Datasets · License: Public Domain · 2021

Open Source ↗

cholangiocarcinoma colorectalcancer ovariancancer pancreaticductaladenocarcinoma smallcelllungcancer

minimal residual disease, kras g12d, kras g12r, nras g12d, nras g12r, pancreatic ductal adenocarcinoma, colorectal cancer, non-small cell lung cancer, ovarian cancer, cholangiocarcinoma, bile duct cancer, gallbladder carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 1008188
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.